基本信息
浏览量:22
职业迁徙
个人简介
Many of the drugs currently taken are active at proteins that sit on the surface of cells called G protein coupled receptors (GPCRs). These drugs include beta-blockers to treat heart disease, antihistamines to treat hay fever and drugs that relieve the symptoms of asthma. My laboratory is interested in how to make drugs that act on GPCRs specifically in the brain for the treatment of neurodegenerative disease such as Alzheimer's disease. Over the last year my laboratory has made substantial progress in this area. We have found that by developing a new type of drug called an allosteric modulator that acts on a specific GPCR (the acetylcholine M1-muscarinic receptor) we are able to not only rescue the loss of memory in a mouse model of neurodegeneration but importantly we have shown that we can slow the progression of the disease. We believe that this novel finding opens the door to developing these drugs for use in people. As such we have started major collaborations with pharmaceutical companies including Eli Lilly and with centres of excellence in Australia and the USA to ask whether we can develop the findings into new medicines for Alzheimer's disease.
研究兴趣
论文共 31 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Irene Fasciani,Francesco Petragnano, Ziming Wang,Ruairidh Edwards, Narasimha Telugu,Ilaria Pietrantoni,Ulrike Zabel,Henrik Zauber, Marlies Grieben, Maria E Terzenidou,Jacopo Di Gregorio,Cristina Pellegrini,
European journal of medicinal chemistry (2023): 115588-115588
NEUROPSYCHOPHARMACOLOGY (2022): 339-340
引用0浏览0引用
0
0
biorxiv(2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn